We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

122 hedge funds and large institutions have $197M invested in Rigel Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 41 increasing their positions, 44 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more call options, than puts

Call options by funds: $57K | Put options by funds: $38K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 123 → 122 (-1)

7% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 44

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

22% less capital invested

Capital invested by funds: $253M → $197M (-$56M)

Holders
122
Holders Change
-1
Holders Change %
-0.81%
% of All Funds
3.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
41
Reduced
44
Closed
10
Calls
$57K
Puts
$38K
Net Calls
+$19K
Net Calls Change
+$253K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.6M
2
Axa
Axa
France
+$1.94M
3
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
+$1.64M
4
NSEDCP
NJ State Employees Deferred Compensation Plan
New Jersey
+$761K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$597K

Top Sellers

1
BC
Broadfin Capital
New York
-$2.24M
2
NI
Numeric Investors
Massachusetts
-$1.14M
3
Two Sigma Investments
Two Sigma Investments
New York
-$886K
4
TC
TFS Capital
Pennsylvania
-$650K
5
OAM
Oxford Asset Management
United Kingdom
-$624K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$32.8M +$161K +5,406 +0.4%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$14.5M +$2.6M +87,113 +17%
PAI
3
Palo Alto Investors
California
$12.8M – – –
BC
4
Broadfin Capital
New York
$12.7M -$2.24M -75,147 -13%
O
5
OppenheimerFunds
New York
$12.3M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$8.07M +$296K +9,912 +3%
BIT
7
BlackRock Institutional Trust
California
$8.06M -$477K -15,977 -5%
NMC
8
NEA Management Company
Maryland
$8.01M – – –
DM
9
Deerfield Management
New York
$5.92M – – –
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$5.67M +$146K +4,877 +2%
BFA
11
BlackRock Fund Advisors
California
$5.62M -$78.9K -2,643 -1%
Axa
12
Axa
France
$4.88M +$1.94M +65,077 +49%
UBS AM
13
UBS AM
Illinois
$4.83M – – –
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$4.51M +$597K +20,004 +12%
Millennium Management
15
Millennium Management
New York
$4.14M -$236K -7,921 -5%
TC
16
TFS Capital
Pennsylvania
$3.78M -$650K -21,792 -12%
State Street
17
State Street
Massachusetts
$3.55M -$65.9K -2,209 -2%
SAM
18
Senzar Asset Management
New York
$3.4M +$594K +19,910 +17%
DCM
19
DAFNA Capital Management
California
$2.74M – – –
RPAM
20
Rhenman & Partners Asset Management
Sweden
$2.29M – – –
Northern Trust
21
Northern Trust
Illinois
$2.25M +$185K +6,206 +7%
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$2.18M – – –
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$1.88M +$289K +9,700 +15%
Marshall Wace
24
Marshall Wace
United Kingdom
$1.79M +$85.8K +2,874 +4%
NI
25
Numeric Investors
Massachusetts
$1.74M -$1.14M -38,328 -35%
1
2 3 4 5

RIGL Hedge Fund Activity: Q3 2015 in Review

122 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2015, worth a combined $197M — down 22% from $253M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RIGL and 9 opened new positions — a net loss of 1 holder — while 44 trimmed existing stakes and 41 added.

The largest buyer was Wellington Management Group, adding an estimated $2.6M. The largest seller was Broadfin Capital, cutting an estimated $2.24M.

  • 122 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2015, down from 123 in Q2 2015.
  • Funds reported $197M of Rigel Pharmaceuticals stock for Q3 2015, down 22% quarter-over-quarter.
  • 9 funds opened new Rigel Pharmaceuticals positions in Q3 2015 and 10 closed out, a net change of -1 holder.
  • The largest Rigel Pharmaceuticals buyer in Q3 2015 was Wellington Management Group, an estimated $2.6M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2015 was Broadfin Capital, an estimated $2.24M sold.

Based on aggregated 13F filings for Q3 2015.